Status:

Red

Decision Date:

February 2020

Comments

RED: NICE TA617 - for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure.

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 4: Specifically designated as “hospital only” by product licence or by DH/NICE

search again